Circle Cardiovascular Imaging vs TeraRecon

Cardiac CT and MR labs are the buyers these two share. Circle's openFDA list includes cvi42 Coronary Plaque (K251027), Cardiac CT Function (K241038) and Myocardial Strain (K232661). TeraRecon's cleared cardiac algorithms are Cardiac.Chambers.MR (K241312) and Cardiovascular.Calcification.CT (K250288), a coronary calcium mask, and TeraRecon says its Intuition platform adds cardiac MR workflows for 2D flow, perfusion and strain. Its DETECT page lists a Plaque Analysis module for cardiac CT and cites FDA-cleared biomarkers without naming one, so for a plaque-led lab TeraRecon trails Circle.

TeraRecon's other buyer is a health system running many AI vendors. TeraRecon says its AI Framework hosts partner algorithms such as Infervision and Gleamer, runs several per study and returns results over DICOM and HL7. It claims over 2,000 hospitals. Its About page says SymphonyAI acquired it in 2020, and its newsroom has titled releases ConcertAI's TeraRecon since 2024.